Alira Health buys Clinical Assistance Programs

| By | Clinical Trials

Alira Health, an international healthcare and life science advisory firm, announced that it has acquired Clinical Assistance Programs (CAP), a contract research organization providing a full range of clinical trial management and consulting services.

The purchase will strengthen Alira Health’s scientific and clinical core. The combined organization will provide a full range of services across regulatory, clinical research and medical affairs. This expansion reinforces Alira Health’s commitment to simplifying their clients’ complex journey through the healthcare and life science product lifecycle.

“CAP’s expertise in clinical trial management is a perfect complement to our suite of services. This strategic acquisition enhances our ability to support our clients’ drug and device clinical research programs,” said Gabriele Brambilla, CEO of Alira Health. “With the addition of CAP’s outstanding team, Alira Health continues its focus on advancing innovation in healthcare.”

“This acquisition will provide CAP with access to additional scientific expertise, enhance our regulatory and therapeutic service offerings and expand our geographic reach. CAP and Alira Health share collaborative, quality-driven cultures and a strategic vision.” said Harry Barnett, JD, Managing Partner of Clinical Assistance Programs.

Founded in 1999, Alira Health, provides integrated strategy, execution and innovation services to help businesses bring pharma, medical technology and healthcare IT to market. Company has offices in six locations across the United States and Europe, including Boston, San Francisco, Munich, Paris, Milan and Barcelona.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.